Events, By Category and Date:

Read coverage of this story from Elizabeth Church.

• Halifax professor campaigns for increased access to drug-safety data. Globe & Mail, 22 Dec 2015.

In the following explanatory blog, Matthew Herder issues a call to action directed at physicians, biomedical researchers, health care professionals, civil society, investigative journalists and others to take advantage of a new mechanism in Canadian law that has the potential to open up data about the safety and effectiveness of drugs.

• Enacting pharmaceutical transparency—Who, what, how, when & why. All Trials. 21 Dec 2015.
• Enacting pharmaceutical transparency—Who, what, how, when & why. Impact Ethics . 21 Dec 2015.

Download the provided template letter: it can be used to request from Health Canada access to all unpublished information, including clinical trials and other investigational studies, pertaining to the safety and effectiveness of a given therapeutiic product about which you would be interested to find out more information.

Finally, read Matthew's original article,

• Reinstitutionalizing transparency at Health Canada.Canadian Medical Association Journal  [PDF 192 KB - Open Access]. Early release, published at www.cmaj.ca, 22 Dec 2015.